Efficacy of Il-1β blockade in refractory aseptic abscesses syndrome
Authors:
- 22 November 2013
- journal article
- Published by Oxford University Press (OUP) in Modern Rheumatology
- Vol. 24 (1) , 217-219
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 geneInflammatory Bowel Diseases, 2011
- Efficacy of Anti-Interleukin-1 Receptor Antagonist Anakinra (Kineret®) in a Case of Refractory Sweet’s SyndromeDermatology, 2011
- Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinraBritish Journal of Dermatology, 2009
- Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial respondersRheumatology, 2007
- Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonistThe Lancet, 2004